Institutional investors hold a majority ownership of AMGN through the 83.48% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 1.4 Million shares of Amgen
KLP KAPITALFORVALTNING AS Bought 157.6 Thousand shares of Amgen
FLOSSBACH VON STORCH AG Bought 146.7 Thousand shares of Amgen